BioNexus Gene Lab Corp (BGLC) AI Dilution Summary
Updated Oct 21, 2026
BGLC is funding itself through its active Maxim Group LLC ATM, authorised to $20,000,000; its most recent capital raised is ATM sales through 2026-08-14, with 53,478 shares sold for $267,311 since the program began and later sales not yet reported. Cash was $2,391,945 at 2026-06-30 against estimated monthly burn of $140,830.